Short Interest in Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) Drops By 20.3%

Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) was the recipient of a large drop in short interest in October. As of October 15th, there was short interest totalling 91,600 shares, a drop of 20.3% from the September 30th total of 115,000 shares. Based on an average daily volume of 13,900 shares, the short-interest ratio is currently 6.6 days.

Medexus Pharmaceuticals Price Performance

MEDXF stock remained flat at $1.85 during midday trading on Friday. The company had a trading volume of 8,345 shares, compared to its average volume of 15,104. The business has a fifty day moving average of $1.87 and a 200-day moving average of $1.55. Medexus Pharmaceuticals has a 12-month low of $1.06 and a 12-month high of $2.35.

About Medexus Pharmaceuticals

Medexus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.